Clinical Pharmacokinetics of Cyclophosphamide
- 1 March 1991
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 20 (3), 194-208
- https://doi.org/10.2165/00003088-199120030-00002
Abstract
Cyclophosphamide has been in clinical use for the treatment of malignant disease for over 30 years. It remains one of the most useful anticancer agents, and is also widely used for its...Keywords
This publication has 77 references indexed in Scilit:
- The Uptake and Metabolism of Cyclophosphamide by the OvarySelective Cancer Therapeutics, 1990
- Clinical Pharmacokinetics-Pharmacodynamicsof Anticancer DrugsClinical Pharmacokinetics, 1989
- Carcinoma of the Urinary Bladder after Treatment with Cyclophosphamide for Non-Hodgkin's LymphomaNew England Journal of Medicine, 1988
- The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast CancerNew England Journal of Medicine, 1988
- Risk of Second Cancers after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1988
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerNew England Journal of Medicine, 1981
- Studies on the antidiuretic effect of cyclophosphamide: Vasopressin release and sodium excretionMedical and Pediatric Oncology, 1980
- Decreased half life of cyclophosphamide in patients under continual treatmentEuropean Journal of Cancer (1965), 1979
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 1979
- Isolation and mass spectral identification of blood metabolities of cyclophosphamide: Evidence for phosphoramide mustard as the biologically active metaboliteJournal of Mass Spectrometry, 1975